<i>MYO1E</i>Mutations and Childhood Familial Focal Segmental GlomerulosclerosisCaterina Mele, Marina Noris, Roberta Donadelli et al.|New England Journal of Medicine|2011Cited by 251
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathyPaola Cassis, Carla Zoja|JCI Insight|2018Cited by 172
ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental DiabetesPaola Cassis, Carla Zoja|Diabetes|2018Cited by 14